These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 23493161)

  • 41. [Neurocysticercosis and immigration].
    Giménez-Roldán S; Diaz F; Esquivel A
    Neurologia; 2003 Sep; 18(7):385-8. PubMed ID: 14505246
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mesocestoides corti intracranial infection as a murine model for neurocysticercosis.
    Alvarez JI; Mishra BB; Gundra UM; Mishra PK; Teale JM
    Parasitology; 2010 Mar; 137(3):359-72. PubMed ID: 20109250
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intraventricular Taenia solium neurocysticercosis: a report of three cases.
    Pant B; Devleesschauwer B; Shrestha P; Shrestha I; Praet N; Dorny P
    JNMA J Nepal Med Assoc; 2011; 51(184):192-5. PubMed ID: 22922900
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An epidemiological study of asymptomatic neurocysticercosis in a pig farming community in northern India.
    Prasad KN; Verma A; Srivastava S; Gupta RK; Pandey CM; Paliwal VK
    Trans R Soc Trop Med Hyg; 2011 Sep; 105(9):531-6. PubMed ID: 21764415
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neurocysticercosis.
    Del Brutto OH
    Semin Neurol; 2005 Sep; 25(3):243-51. PubMed ID: 16170737
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Association of MMP-2 and MMP-9 with clinical outcome of neurocysticercosis.
    Verma A; Prasad KN; Nyati KK; Singh SK; Singh AK; Paliwal VK; Gupta RK
    Parasitology; 2011 Sep; 138(11):1423-8. PubMed ID: 21813044
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Medical management of neurocysticercosis.
    Takayanagui OM; Odashima NS; Bonato PS; Lima JE; Lanchote VL
    Expert Opin Pharmacother; 2011 Dec; 12(18):2845-56. PubMed ID: 22082143
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of excretory secretory and 10-30 kDa antigens of Taenia solium Cysticerci by EITB assay for the diagnosis of neurocysticercosis.
    Atluri SR; Singhi P; Khandelwal N; Malla N
    Parasite Immunol; 2009 Mar; 31(3):151-5. PubMed ID: 19222787
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Next-generation sequencing combined with serological tests based pathogen analysis for a neurocysticercosis patient with a 20-year history:a case report.
    Chen B; Chen Z; Yang YS; Cai GL; Xu XJ; Guan HZ; Ren HT; Tuo HZ
    BMC Neurol; 2021 Jun; 21(1):236. PubMed ID: 34167488
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sorting out difficulties in immunological diagnosis of neurocysticercosis: Development and assessment of real time loop mediated isothermal amplification of cysticercal DNA in blood.
    Goyal G; Phukan AC; Hussain M; Lal V; Modi M; Goyal MK; Sehgal R
    J Neurol Sci; 2020 Jan; 408():116544. PubMed ID: 31759221
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mass Spectrometry Identifies Taenia solium Proteins in Sera of Patients With and Without Parenchymal Neurocysticercosis.
    Pamela BE; Patole C; Thamizhmaran S; Moorthy RK; Manoj J; Thanigachalam A; Hocker JRS; Drevets DA; Oommen A; Rajshekhar V; Carabin H; Vasudevan P
    Parasite Immunol; 2024 Jul; 46(7):e13058. PubMed ID: 39072810
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cerebrovascular complications of neurocysticercosis.
    Marquez JM; Arauz A
    Neurologist; 2012 Jan; 18(1):17-22. PubMed ID: 22217610
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Neurocysticercosis: A case study of a Mongolian traveler who visited China and India with an updated review in Asia.
    Davaasuren A; Davaajav A; Ukhnaa B; Purvee A; Unurkhaan S; Luvsan A; Logan JE; Ito A
    Travel Med Infect Dis; 2017; 20():31-36. PubMed ID: 28478337
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical characteristics and management of neurocysticercosis patients: a retrospective assessment of case reports from Europe.
    Stelzle D; Abraham A; Kaminski M; Schmidt V; De Meijere R; Bustos JA; Garcia HH; Sahu PS; Bobić B; Cretu C; Chiodini P; Dermauw V; Devleesschauwer B; Dorny P; Fonseca A; Gabriël S; Morales MÁG; Laranjo-González M; Hoerauf A; Hunter E; Jambou R; Jurhar-Pavlova M; Reiter-Owona I; Sotiraki S; Trevisan C; Vilhena M; Walker NF; Zammarchi L; Winkler AS
    J Travel Med; 2023 Feb; 30(1):. PubMed ID: 36222148
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neurocysticercosis in immigrant populations.
    Garcia HH;
    J Travel Med; 2012; 19(2):73-5. PubMed ID: 22414030
    [No Abstract]   [Full Text] [Related]  

  • 56. Reprint of "Neurocysticercosis-related mortality in Brazil, 2000-2011: Epidemiology of a neglected neurologic cause of death".
    Martins-Melo FR; Ramos AN; Cavalcanti MG; Alencar CH; Heukelbach J
    Acta Trop; 2017 Jan; 165():170-178. PubMed ID: 27887696
    [TBL] [Abstract][Full Text] [Related]  

  • 57. New developments in the management of neurocysticercosis.
    White AC
    J Infect Dis; 2009 May; 199(9):1261-2. PubMed ID: 19358667
    [No Abstract]   [Full Text] [Related]  

  • 58. Current approaches to cysticidal drug therapy for neurocysticercosis.
    Del Brutto OH
    Expert Rev Anti Infect Ther; 2020 Aug; 18(8):789-798. PubMed ID: 32331507
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Taenia solium: identification of specific antibody binding regions of metacestode 10-kDa protein.
    Chung JY; Yun DH; Eom KS; Kang SY; Kong Y; Cho SY
    Exp Parasitol; 2002 Feb; 100(2):87-94. PubMed ID: 12054698
    [TBL] [Abstract][Full Text] [Related]  

  • 60. What triggers seizures in neurocysticercosis? A MRI-based study in pig farming community from a district of North India.
    Prasad A; Gupta RK; Pradhan S; Tripathi M; Pandey CM; Prasad KN
    Parasitol Int; 2008 Jun; 57(2):166-71. PubMed ID: 18234551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.